pic.twitter.com/nzyOZwVBxHWe also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task.
Even the most advanced countries and companies are struggling in relatively smaller populations, he said.Secondly, we have been working closely with Government of India since April last year.
We have got all kinds of support, be it scientific, regulatory and financial. As of today, we received total orders of over 26 crore doses, of which we supplied more than S crore doses.
We have also got 100% advance of ₹1,732.5 crore by the government for the next tranche of 11 crore doses in the next few months.